Status:
WITHDRAWN
Study of Endothelial Cells in Patients With Hereditary Haemorrhagic Telangiectasia
Lead Sponsor:
Imperial College London
Conditions:
Telangiectasia, Hereditary Hemorrhagic
Eligibility:
All Genders
Brief Summary
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels. We propose to culture endotheli...
Eligibility Criteria
Inclusion
- Patients with hereditary haemorrhagic telangiectasia and family members
Exclusion
- Unable to provide informed consent
Key Trial Info
Start Date :
August 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00733629
Start Date
August 1 2002
End Date
March 1 2006
Last Update
October 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College Hammersmith Campus
London, United Kingdom, W12 0NN